ERCC5 and neoplasm: For levels of gene expression, Kaplan–Meier (KM) estimator and hazard ratios (HR) indicated that in 3 out of 33 TCGA tumor types, low (below mean) ERCC5 expression was a risk factor correlating with poor patient survival.